GLL Health Sciences Fund Ltd Submits SEC Filing
GLL Health Sciences Fund Ltd, identified by CIK number 0001694196, filed a document with the SEC on March 31, 2026, under Item 3C of the Investment Company Act, specifically Item 3C.7 for Section 3(c)(7), according to SEC EDGAR.
Filing Details
The filing, with Accession Number 0001694196-26-000003, was submitted on 2026-03-31 and has a size of 10 KB. It pertains directly to Item 3C.7, which references Section 3(c)(7) of the Investment Company Act. GLL Health Sciences Fund Ltd is listed as the filer in this SEC EDGAR record.
Context of the Investment Company Act
As is widely known, the Investment Company Act regulates investment funds, and Section 3(c)(7) provides an exemption for certain private funds. This filing by GLL Health Sciences Fund Ltd aligns with that section, according to SEC EDGAR.
Implications in Brief
The document’s focus on Item 3C.7 indicates it relates to the specific provisions of Section 3(c)(7), as detailed in the SEC EDGAR filing dated 2026-03-31, according to SEC EDGAR.
